Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys Medical
27 sept. 2019 14h50 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
14 août 2019 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Announces CE Mark Approval for Nexus
12 août 2019 11h20 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Report Fiscal 2019 Fourth Quarter Financial Results and Host Conference Call and Webcast on August 14
07 août 2019 14h00 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8
18 juil. 2019 10h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Announces Inclusion in the Russell 2000® and 3000 Indexes
01 juil. 2019 07h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., July 01, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
SEC Investigation of Misonix, Inc. Ends With No Action
20 juin 2019 11h00 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., June 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes,...
Misonix Receives U.S. FDA Clearance for Nexus, its Revolutionary Integrated Ultrasonic Surgical Platform
03 juin 2019 07h00 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., June 03, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29
20 mai 2019 07h30 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Reports Fiscal 2019 Third Quarter Revenue of $9.6 Million
08 mai 2019 16h05 HE
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 08, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...